GH Research (GHRS) Payables (2021 - 2026)

GH Research (GHRS) posted quarterly Payables of $3.8 million for Q4 2025, up 0.86% year-over-year from $3.7 million in Q4 2024, and down 1.67% quarter-over-quarter from $3.8 million in Q3 2025.

GH Research (GHRS) Payables (2021 - 2026) Analysis & Trends

GH Research's Payables history runs 5 years deep, the most recent figure standing at $3.8 million for Q4 2025.

  • In Q4 2025, Payables rose 0.86% year-over-year to $3.8 million; the TTM figure through Dec 2025 stood at $3.8 million (up 0.86% YoY), while the FY2025 annual figure was $3.8 million, up 0.86% from the prior year.
  • Payables for Q4 2025 stood at $3.8 million, down from $3.8 million in the prior quarter.
  • The five-year high for Payables was $4.8 million in Q1 2025, with the low at $399000.0 in Q4 2021.
  • The 5-year median for Payables is $2.9 million (2023), against an average of $2.7 million.
  • The sharpest annual moves came in 2022 and 2024: Payables surged 368.17% in 2022, then retreated 11.68% in 2024.
  • GH Research's Payables stood at $399000.0 in 2021, then soared by 368.17% to $1.9 million in 2022, then soared by 86.83% to $3.5 million in 2023, then grew by 7.19% to $3.7 million in 2024, then gained by 0.86% to $3.8 million in 2025.
  • Business Quant data shows GHRS's Payables at $3.8 million in Q4 2025, $3.8 million in Q3 2025, and $3.4 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.52 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 88.42 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 470.30 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3.05 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 35.57 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 108.02 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 428.93 Mn
10 GH Research 2.02 Bn 1.68 Bn - 5.93 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 5.93 Mn
Dec 31, 2025 3.77 Mn
Sep 30, 2025 3.84 Mn
Jun 30, 2025 3.45 Mn
Mar 31, 2025 4.77 Mn
Dec 31, 2024 3.74 Mn
Sep 30, 2024 2.95 Mn
Jun 30, 2024 2.57 Mn
Mar 31, 2024 3.55 Mn
Dec 31, 2023 3.49 Mn
Sep 30, 2023 2.71 Mn
Jun 30, 2023 2.91 Mn
Mar 31, 2023 2.93 Mn
Dec 31, 2022 1.87 Mn
Sep 30, 2022 1.75 Mn
Jun 30, 2022 1.71 Mn
Mar 31, 2022 1.55 Mn
Dec 31, 2021 399,000.00
Sep 30, 2021 1.21 Mn